Soumitra S Bhuyan - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Soumitra S Bhuyan's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Soumitra S Bhuyan

Soumitra S Bhuyan

Verified

Associate Professor, EJB Talks: Rutgers Bloustein School Experts

New Jersey, Guwahati

Doesn’t Cover

There’s nothing I can’t do lol.

Journalist Type

-

Seniority Positions

Medium Formats

Content

Total articles 130

  • Significant Correlation Found Between Select Calcitonin Values and MTC

    By Soumitra S Bhuyan| Rare Disease Advisor@ A recent systematic review and meta-analysis published in Reviews in Endocrine and Metabolic Disorders has found promising results regarding the prevalence of indeterminate calcitonin values (ICV) in patients with medullary thyroid carcinoma (MTC). The study found that the percentage of ICV among patients with thyroid nodules who underwent calcitonin(Ctn) testing was negligible, and the risk of MTC significantly increased in ICV intervals when the Ctn level went above 20 pg/mL.

    By Soumitra S Bhuyan · Rare Disease Advisor

    Jul. 16, 2023

  • Alglucosidase Alfa May Be Safe for Home-Based Infusion in LOPD Care

    By Soumitra S Bhuyan| Rare Disease Advisor@ A recent study published in BioDrugs has revealed that alglucosidase alfa can be safely administered at home in adult patients with late-onset Pompe disease (LOPD), given a fewer infusion-associated reactions (IARs) occur and that the majority of IARs are mild.

    By Soumitra S Bhuyan · Rare Disease Advisor

    Jul. 12, 2023

  • Significant Correlation Found Between Select Calcitonin Values and MTC

    By Soumitra S Bhuyan| Rare Disease Advisor@ A recent systematic review and meta-analysis published in Reviews in Endocrine and Metabolic Disorders has found promising results regarding the prevalence of indeterminate calcitonin values (ICV) in patients with medullary thyroid carcinoma (MTC). The study found that the percentage of ICV among patients with thyroid nodules who underwent calcitonin(Ctn) testing was negligible, and the risk of MTC significantly increased in ICV intervals when the Ctn level went above 20 pg/mL.

    By Soumitra S Bhuyan · Rare Disease Advisor

    Jul. 16, 2023

As seen in

Company Info

EJB Talks: Rutgers Bloustein School Experts

New Brunswick, New Jersey, United States

+1 973-353-5541